A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Abstract Background Alzheimer’s disease (AD) is characterized by cognitive dysfunction and amyloid plaques composed of the amyloid-beta peptide (Aβ). APOE is the greatest genetic risk for AD with APOE4 increasing risk up to ~ 15-fold compared to APOE3. Evidence suggests that levels and lipidation of...
Main Authors: | Ana C. Valencia-Olvera, Deebika Balu, Shreya Bellur, Thomas McNally, Yaseen Saleh, Don Pham, Shivesh Ghura, Jason York, Jan O. Johansson, Mary Jo LaDu, Leon Tai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-023-01353-z |
Similar Items
-
APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
by: Deebika Balu, et al.
Published: (2023-10-01) -
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
by: Deebika Balu, et al.
Published: (2023-10-01) -
The Role of APOE and NF-κB in Alzheimer’s Disease
by: Don A. Davies
Published: (2021-10-01) -
Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy
by: Anna Bonaterra-Pastra, et al.
Published: (2023-04-01) -
Liver-ing in your head rent free: peripheral ApoE4 drives CNS pathology
by: Lesley R. Golden, et al.
Published: (2022-10-01)